Empagliflozin adjunct with insulin pump therapy enhanced glycemic control and β-cell function in patients with long-standing type 2 diabetes

Institutions

Publication Details

Journal
AACE Endocrinology and Diabetes
Published
2026-04-01
DOI
https://doi.org/10.1016/j.aed.2026.03.010
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Empagliflozin adjunct with insulin pump therapy enhanced glycemic control and β-cell function in patients with long-standing type 2 diabetes

AACE Endocrinology and Diabetes
Diabetes Treatment and Management
article

Empagliflozin adjunct with insulin pump therapy enhanced glycemic control and β-cell function in patients with long-standing type 2 diabetes

article en

Abstract

No abstract available for this paper.
AACE Endocrinology and Diabetes
Korea National University of Transportation (KR), Konkuk University (KR), Chungbuk National University Hospital (KR)
Openalex Percentile: Top 24%
Diabetes Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Empagliflozin adjunct with insulin pump therapy enhanced glycemic control and β-cell function in patients with long-standing type 2 diabetes · AACE Endocrinology and Diabetes (2026) | TGRS Research Map | TGRS